Pacira BioSciences, Inc. (NASDAQ: PCRX)

Pacira BioSciences, Inc. (PCRX) is a biopharmaceutical company that operates in the healthcare industry. The company specializes in the development and commercialization of non-opioid pain management products, with a focus on providing long-lasting pain relief without the use of opioids. Pacira was incorporated in 2006 and has its principal executive offices and corporate headquarters located in Tampa, Florida.

Pacira's main business activities involve the development and commercialization of non-opioid pain management products, including EXPAREL, ZILRETTA, and iovera°. EXPAREL is a long-acting, local analgesic used to manage postsurgical pain, administered as a single-dose infiltration, and provides pain relief for up to four days. EXPAREL is approved for use in patients aged six years and older and is used in a variety of surgical procedures such as orthopedic, abdominal, and cardiothoracic surgeries. ZILRETTA is an extended-release, intra-articular corticosteroid used to manage osteoarthritis (OA) knee pain, administered as a single injection, and provides pain relief for up to 12 weeks. ZILRETTA is approved for use in patients with OA knee pain and is used in conjunction with physical therapy and other non-pharmacological interventions. iovera° is a non-opioid, handheld cryoanalgesia device used to produce precise, controlled doses of cold temperature to targeted nerves, and is used to manage chronic pain conditions, including OA pain of the knee. iovera° is FDA 510(k) cleared and has a CE mark in the European Union.

Pacira's position within the industry is strong, with a portfolio of non-opioid pain management products that are used in a variety of surgical procedures. The company's products are designed to provide long-lasting pain relief without the use of opioids, which are often associated with addiction and other serious side effects. Pacira's products are used by healthcare professionals throughout the United States and internationally, and include major healthcare systems, academic medical centers, and community hospitals.

Pacira's customers include hospitals, ambulatory surgery centers, and physician offices. The company's products are used by healthcare professionals, including anesthesiologists, surgeons, and pain management specialists. The EXPAREL segment includes Pacira's long-acting, local analgesic product, EXPAREL, used to manage postsurgical pain and administered as a single-dose infiltration. The ZILRETTA segment includes Pacira's extended-release, intra-articular corticosteroid product, ZILRETTA, used to manage osteoarthritis (OA) knee pain and administered as a single injection. The iovera° segment includes Pacira's non-opioid, handheld cryoanalgesia device, iovera°, used to produce precise, controlled doses of cold temperature to targeted nerves and is used to manage chronic pain conditions, including OA pain of the knee.